No Data
No Data
Psychedelic Stocks Fall as FDA Panel Rejects MDMA Therapy
FDA Advisory Panel Fails to Endorse Psychedelic MDMA Therapy for PTSD
Psychedelic Stocks Mixed as FDA Comments on MDMA Therapy
CureVac, Oragenics, IGM Biosciences Among Healthcare Movers
PLAB, MMAT and HBM Among Pre-market Losers
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAkanda (NASDAQ:AKAN) shares rose 177.7% to $0.37 during Friday's pre-market session. The company's market cap stands at $11.7 million. Scorpius Holdings (AMEX:SCPX) stock increased by 28.17% to
No Data